Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.8540
+0.0425 (5.24%)
Nov 4, 2025, 9:34 AM EST - Market open
Xtant Medical Holdings Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Xtant Medical Holdings in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Xtant Medical Holdings.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $2 → $3 | Strong Buy | Maintains | $2 → $3 | +251.31% | May 16, 2024 |
| BTIG | BTIG | Strong Buy Initiates $2 | Strong Buy | Initiates | $2 | +134.21% | Dec 5, 2023 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $1 → $1.2 | Strong Buy | Maintains | $1 → $1.2 | +40.52% | Jul 11, 2023 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $1 | Strong Buy | Initiates | $1 | +17.10% | Apr 26, 2023 |
Financial Forecast
Revenue This Year
132.55M
from 117.27M
Increased by 13.03%
Revenue Next Year
120.67M
from 132.55M
Decreased by -8.96%
EPS This Year
0.01
from -0.12
EPS Next Year
0.01
from 0.01
Decreased by -50.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 140.5M | 138.8M | |
| Avg | 132.6M | 120.7M | |
| Low | 123.6M | 102.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 19.8% | 4.7% | |
| Avg | 13.0% | -9.0% | |
| Low | 5.4% | -22.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.02 | 0.01 | |
| Avg | 0.01 | 0.01 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 2.9% | |
| Avg | - | -50.0% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.